+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

Q

Actively Recruiting

Researchers are studying the quality of life QoL of adults with Chronic Lymphocytic Leukemia CLL who are treated with acalabrutinib in real-world settings in France. This study aims to better understand how patients QoL changes from the start of treatment up to 12 months after, as this aspect is not often assessed in real-life studies. The research also considers patient demographics, disease characteristics, treatment patterns, and symptom evolution during this period. This is a retrospective observational study using existing data from the French PLATON database, which collects clinical and patient-reported information on hematological malignancies including CLL. Patients included are treatment-naive adults who started acalabrutinib either alone or combined with obinutuzumab. The study will analyze QoL at treatment initiation and then at 3, 6, 9, and 12 months using validated questionnaires such as EORTC QLQ-C30 and QLQ-CLL17. Treatment adherence is also monitored with the GIRERD grid. Participants data are collected routinely during their care and stored securely. The study focuses on analyzing existing information without requiring extra visits or procedures. Researchers will evaluate QoL scores, symptom levels, treatment patterns, and patient satisfaction over time. The study plans to include about 120 patients, with comprehensive data quality checks and statistical analysis performed on the collected data.

All AgesAll Genders
1 location